Biblio

Export 3292 results:
Author Title Type [ Year(Desc)]
Filters: Http is tiny.cc and AIAD is   [Clear All Filters]
2017
D. Cuccaro, De Marco, E. Valeria, Cittadella, R., and Cavallaro, S., “Copy Number Variants in Alzheimer's Disease.”, J Alzheimers Dis, vol. 55, no. 1, pp. 37-52, 2017.
A. R. Morgan, Touchard, S., O'Hagan, C., Sims, R., Majounie, E., Escott-Price, V., Jones, L., Williams, J., and B Morgan, P., “The Correlation between Inflammatory Biomarkers and Polygenic Risk Score in Alzheimer's Disease.”, J Alzheimers Dis, vol. 56, no. 1, pp. 25-36, 2017.
D. A. Ferro, van Veluw, S. J., Koek, H. L., Exalto, L. G., and Biessels, G. Jan, “Cortical Cerebral Microinfarcts on 3 Tesla MRI in Patients with Vascular Cognitive Impairment.”, J Alzheimers Dis, vol. 60, no. 4, pp. 1443-1450, 2017.
S. van Duijn, Bulk, M., van Duinen, S. G., Nabuurs, R. J. A., van Buchem, M. A., van der Weerd, L., and Natté, R., “Cortical Iron Reflects Severity of Alzheimer's Disease.”, J Alzheimers Dis, vol. 60, no. 4, pp. 1533-1545, 2017.
G. H. Weissberger, Melrose, R. J., Fanale, C. M., Veliz, J. V., and Sultzer, D. L., “Cortical Metabolic and Cognitive Correlates of Disorientation in Alzheimer's Disease.”, J Alzheimers Dis, vol. 60, no. 2, pp. 707-719, 2017.
A. Pink, Przybelski, S. A., Krell-Roesch, J., Stokin, G. B., Roberts, R. O., Mielke, M. M., Knopman, D. S., Jack, C. R., Petersen, R. C., and Geda, Y. E., “Cortical Thickness and Depressive Symptoms in Cognitively Normal Individuals: The Mayo Clinic Study of Aging.”, J Alzheimers Dis, vol. 58, no. 4, pp. 1273-1281, 2017.
Z. Wang, Dai, Z., Shu, H., Liu, D., Guo, Q., He, Y., and Zhang, Z., “Cortical Thickness and Microstructural White Matter Changes Detect Amnestic Mild Cognitive Impairment.”, J Alzheimers Dis, vol. 56, no. 1, pp. 415-428, 2017.
R. L. H. Handels, Wimo, A., Dodel, R., Kramberger, M. G., Visser, P. Jelle, Molinuevo, J. Luis, Verhey, F. R. J., and Winblad, B., “Cost-Utility of Using Alzheimer's Disease Biomarkers in Cerebrospinal Fluid to Predict Progression from Mild Cognitive Impairment to Dementia.”, J Alzheimers Dis, vol. 60, no. 4, pp. 1477-1487, 2017.
H. P Reddy, “A Critical Assessment of Research on Neurotransmitters in Alzheimer's Disease.”, J Alzheimers Dis, vol. 57, no. 4, pp. 969-974, 2017.
C. O'Driscoll and Shaikh, M., “Cross-Cultural Applicability of the Montreal Cognitive Assessment (MoCA): A Systematic Review.”, J Alzheimers Dis, vol. 58, no. 3, pp. 789-801, 2017.
M. Buongiorno, Antonelli, F., Compta, Y., Fernandez, Y., Pavía, J., Lomeña, F., Ríos, J., Ramírez, I., García, J. Ramón, Soler, M., Cámara, A., Fernández, M., Basora, M., Salazar, F., Sanchez-Etayo, G., Valldeoriola, F., Barrio, J. Raúl, and Marti, M. Jose, “Cross-Sectional and Longitudinal Cognitive Correlates of FDDNP PET and CSF Amyloid-β and Tau in Parkinson's Disease1.”, J Alzheimers Dis, vol. 55, no. 3, pp. 1261-1272, 2017.
L. Iaccarino, Chiotis, K., Alongi, P., Almkvist, O., Wall, A., Cerami, C., Bettinardi, V., Gianolli, L., Nordberg, A., and Perani, D., “A Cross-Validation of FDG- and Amyloid-PET Biomarkers in Mild Cognitive Impairment for the Risk Prediction to Dementia due to Alzheimer's Disease in a Clinical Setting.”, J Alzheimers Dis, vol. 59, no. 2, pp. 603-614, 2017.
J. Raja Sundaram, Poore, C. Priscilla, Bin Sulaimee, N. Hazim, Pareek, T., Cheong, W. Fun, Wenk, M. R., Pant, H. C., Frautschy, S. A., Low, C. - M., and Kesavapany, S., “Curcumin Ameliorates Neuroinflammation, Neurodegeneration, and Memory Deficits in p25 Transgenic Mouse Model that Bears Hallmarks of Alzheimer's Disease.”, J Alzheimers Dis, vol. 60, no. 4, pp. 1429-1442, 2017.
J. Subhash Rane, Bhaumik, P., and Panda, D., “Curcumin Inhibits Tau Aggregation and Disintegrates Preformed Tau Filaments in vitro.”, J Alzheimers Dis, vol. 60, no. 3, pp. 999-1014, 2017.
A. - M. Miller, Balasa, M., Blennow, K., Gardiner, M., Rutkowska, A., Scheltens, P., Teunissen, C. E., Visser, P. Jelle, Winblad, B., Waldemar, G., and Lawlor, B., “Current Approaches and Clinician Attitudes to the Use of Cerebrospinal Fluid Biomarkers in Diagnostic Evaluation of Dementia in Europe.”, J Alzheimers Dis, vol. 60, no. 1, pp. 201-210, 2017.
C. L. Fisher, Resnick, R. J., De, S., Acevedo, L. A., Lu, K. Ping, Schroeder, F. C., and Nicholson, L. K., “Cyclic cis-Locked Phospho-Dipeptides Reduce Entry of AβPP into Amyloidogenic Processing Pathway.”, J Alzheimers Dis, vol. 55, no. 1, pp. 391-410, 2017.
E. Gauba, Guo, L., and Du, H., “Cyclophilin D Promotes Brain Mitochondrial F1FO ATP Synthase Dysfunction in Aging Mice.”, J Alzheimers Dis, vol. 55, no. 4, pp. 1351-1362, 2017.
V. R. Varma and Watts, A., “Daily Physical Activity Patterns During the Early Stage of Alzheimer's Disease.”, J Alzheimers Dis, vol. 55, no. 2, pp. 659-667, 2017.
L. Serra, Gabrielli, G. Bechi, Tuzzi, E., Spanò, B., Giulietti, G., Failoni, V., Marra, C., Caltagirone, C., Koch, G., Cercignani, M., and Bozzali, M., “Damage to the Frontal Aslant Tract Accounts for Visuo-Constructive Deficits in Alzheimer's Disease.”, J Alzheimers Dis, vol. 60, no. 3, pp. 1015-1024, 2017.
M. Nakanishi, Niimura, J., Yamasaki, S., and Nishida, A., “Death of Dementia Patients in Psychiatric Hospitals and Regional Supply of Psychiatric Services: Study of the National Data from 1996 to 2014 in Japan.”, J Alzheimers Dis, vol. 56, no. 2, pp. 817-824, 2017.
R. Kotani, Urano, Y., Sugimoto, H., and Noguchi, N., “Decrease of Amyloid-β Levels by Curcumin Derivative via Modulation of Amyloid-β Protein Precursor Trafficking.”, J Alzheimers Dis, vol. 56, no. 2, pp. 529-542, 2017.
I. Jurjević, Miyajima, M., Ogino, I., Akiba, C., Nakajima, M., Kondo, A., Kikkawa, M., Kanai, M., Hattori, N., and Arai, H., “Decreased Expression of hsa-miR-4274 in Cerebrospinal Fluid of Normal Pressure Hydrocephalus Mimics with Parkinsonian Syndromes.”, J Alzheimers Dis, vol. 56, no. 1, pp. 317-325, 2017.
T. Sugimoto, Nakamura, A., Kato, T., Iwata, K., Saji, N., Arahata, Y., Hattori, H., Bundo, M., Ito, K., Niida, S., and Sakurai, T., “Decreased Glucose Metabolism in Medial Prefrontal Areas is Associated with Nutritional Status in Patients with Prodromal and Early Alzheimer's Disease.”, J Alzheimers Dis, vol. 60, no. 1, pp. 225-233, 2017.
A. Stoccoro, Siciliano, G., Migliore, L., and Coppedè, F., “Decreased Methylation of the Mitochondrial D-Loop Region in Late-Onset Alzheimer's Disease.”, J Alzheimers Dis, vol. 59, no. 2, pp. 559-564, 2017.
M. Waragai, Moriya, M., and Nojo, T., “Decreased N-Acetyl Aspartate/Myo-Inositol Ratio in the Posterior Cingulate Cortex Shown by Magnetic Resonance Spectroscopy May Be One of the Risk Markers of Preclinical Alzheimer's Disease: A 7-Year Follow-Up Study.”, J Alzheimers Dis, vol. 60, no. 4, pp. 1411-1427, 2017.

Pages